Huifeng Bio-pharmaceutical Technology (fka HFGB)

[pappy]

o.k. So eps won't be $0.22-$0.26 in 2010 as I projected "conservatively"before the new shares were added into that projection.

But the need for added facilities to fill increasing order backlog makes me think eps would have been at the upper end of my projection.

So 2010 eps will only be around $0.19 thats still up from $0.15 last year with like 50% more shares outstanding.

And the new plant is expected to add $20M in revenue gains on a full year basis.

On a per share basis off the top of my head this will add about $0.08 to 2011 eps & about $0.15 to 2012 eps.

With growth like that I don't think you can say this deal was dilutive to eps unless your taking a very shortsighted view.

I for one will be buying the dips as long as HFGB is doing deals that are accretive to longterm growth & can still increase eps this year while doing so..